Milrinone

CHEMBL189 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

211.2 g/mol

LogP

—

Phase

4

This medication strengthens heart contractions and relaxes blood vessels, helping the heart pump more effectively in acute heart failure. It is given intravenously in hospital settings and is not intended for long-term outpatient use.

Masse moléculaire

211,2200 g/mol

LogP

0,00

TPSA

65,80 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Pain Management Asthma Insomnia Hypertension Chronic Pain Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1

InChI

InChI=1S/C12H9N3O/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8/h2-6H,1H3,(H,15,16)

Molecular Formula

C12H9N3O

HBD / HBA

1 / 3

Liaisons Rotatives

1

Atomes Lourds

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This medication strengthens heart contractions and relaxes blood vessels, helping the heart pump more effectively in acute heart failure. It is given intravenously in hospital settings and is not intended for long-term outpatient use.

Yes, Milrinone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL189. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4197. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Milrinone sur PillFYI

Structure

Données Clés

Formule: C12H9N3O
Synonymes: 2

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.